The global cell and gene therapy market by revenue is expected to grow at a CAGR of over 30.90% during the period 20192025 – GlobeNewswire

New York, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Cell & Gene Therapy Market - Global Outlook and Forecast 2020-2025" - https://www.reportlinker.com/p05827567/?utm_source=GNW 90% during the period 20192025.

The global cell and gene therapy market is one of the fastest-growing segments in the regenerative medicine market. The market is expected to grow at a faster pace during the forecast period. The demand can be attributed to the growing prevalence of several chronic diseases such as cancer, cartilage related problems, wounds, diabetic foot ulcer, genetic disorders, and other rare diseases across the globe. The prevalence of cancer and diabetes is increasing in the global population, which is influencing the growth of the market. There is a large unmet need in the treatment available, which is filled by cell and gene therapies. The market is growing due to the increased availability of funding from various public and private institutions. Besides, there is increased support from regulatory bodies for product approval. Several governments are creating awareness of cell and gene therapies in the population.

The following factors are likely to contribute to the growth of the cell and gene therapy market during the forecast period: Increase in Strategic Acquisition Activities Increased Funding for Cell & Gene Therapy Products Expanding Applications of Cell and Gene Therapies Increased in the Patient Pool

The study considers the present scenario of the cell and gene therapy market and its market dynamics for the period 2019?2025. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market. Cell And Gene Therapy Market Segmentation The global cell and gene therapy market research report includes a detailed segmentation by product, disease, end-user, and geography. In 2019, the cell therapy segment accounted for a market share of over 53% in the global cell and gene therapy market. The segment is expected to grow at a steady rate during the forecast period due to the increase in the target population and the rise in the number of countries preferring cell therapies in their patients. Increased therapeutic benefits are attracting several countries to invest in this technology and conduct a high number of clinical trials. However, the lack of advanced infrastructure in developing countries is hindering the growth of the segment.

In 2019, the oncology segment accounted for a share of over 40% in the global cell and gene therapy market. Oncology has been one of the targets of intense research for the gene therapy procedures & approach. More than 60% of on-going gene therapy clinical trials are targeting cancer. The segment is expected to grow at a promising rate on account of the high prevalence of cancer diseases, especially in low and middle-come countries. The market is growing at a double-digit CAGR, which is expected to help the segment as many cell and gene therapy for cancer are commercially available.

The dermatology application segment in the cell and gene therapy includes wound care management among patients. Vendors are focusing on the development and commercialization of advanced wound care products for the treatment of chronic and acute wounds, thereby increasing the growth of the wound care market. The increased pervasiveness of diabetics is increasing acute and chronic wounds, including surgical wounds, pressure ulcers, diabetic foot ulcers, and other wounds.

In 2019, the oncology segment accounted for a share of over 40% in the global cell and gene therapy market. Oncology has been one of the targets of intense research for the gene therapy procedures & approach. More than 60% of on-going gene therapy clinical trials are targeting cancer. The segment is expected to grow at a promising rate on account of the high prevalence of cancer diseases, especially in low and middle-come countries. The market is growing at a double-digit CAGR, which is expected to help the segment as many cell and gene therapy for cancer are commercially available.

The dermatology application segment in the cell and gene therapy includes wound care management among patients. Vendors are focusing on the development and commercialization of advanced wound care products for the treatment of chronic and acute wounds, thereby increasing the growth of the wound care market. The increased pervasiveness of diabetics is increasing acute and chronic wounds, including surgical wounds, pressure ulcers, diabetic foot ulcers, and other wounds.

Segmentation by Product Cell Therapy Gene Therapy Segmentation by Disease Dermatology Musculoskeletal Oncology Genetic Disorders Others Segmentation by End-user Hospitality Cancer Care Centers Wound Care Centers Ambulatory Surgical Centers Others

INSIGHTS BY GEOGRAPHY In 2019, North America accounted for a share of over 60% of the global cell and gene therapy market. There are more than 530 regenerative medicine companies, including cell and gene therapy manufacturing developers. The number of products approved in North America grew significantly in 2019, with developers filed for marketing authorization for 10+ regenerative medicines, many of which we expect to be approved in 2020. Within the next 12 years, the number of approved gene therapies is expected to double. The US and Canada are the major contributors to the cell and gene therapy market in North America. Regulatory bodies are supporting several investigational products, fast track approvals, RMAT designation for the faster approval of the product into the market. The alliance for regenerative medicine and Medicare and Medicaid is working together to bring the structured reimbursement channels for cell and gene therapies.

Segmentation by Geography North America o US o Canada Europe o UK o Germany o France o Spain o Italy APAC o China o Japan o South Korea o Australia o India Latin America o Brazil o Mexico Middle East & Africa o Saudi Arabia o Turkey o South Africa o UAE

INSIGHTS BY VENDORS The global cell and gene therapy market is highly dynamic and characterized by the presence of several global, regional, and local vendors offering a wide range of therapies. Dendreon, Gilead Sciences, Novartis, Organogenesis, Osiris Therapeutics, Vericel, Amgen, and Spark Therapeutics are the leading players in the market with significant shares. Vendors such as NuVasive, APAC Biotech, Nipro, Orthocell, bluebird bio, J-TEC, and Terumo are the other prominent players in the market with a presence, especially in the cell therapy market. Most leading players are focusing on implementing strategies such as product launches and approvals, marketing and promotional activities, acquisitions, increased R&D investments, and strengthening their distribution networks to enhance their share and presence in the market.

Prominent Vendors Gilead Sciences Spark Therapeutics Novartis Organogenesis Amgen Osiris Therapeutics Dendreon Vericel

Other Prominent Vendors Anterogen Tego Sciences Japan Tissue Engineering JCR Pharmaceuticals Medipost MolMed AVITA Medical CollPlant Biosolution Stempeutics Research Kolon Tissue Gene Orchard Therapeutics Sibiono GeneTech NuVasive Corestem Pharmicell Shanghai Sunway Biotech RMS Regenerative Medical System Takeda Pharmaceutical Company CHIESI Farmaceutici CO.DON AnGes GC Pharma Human Stem Cells Institute JW CreaGene APAC Biotech Nipro Terumo Orthocell bluebird bio

Key Questions Answered 1. What is the cell and gene therapy market size and growth rate during the forecast period? 2. What are the factors impacting the growth of the cell and gene therapy market share? 3. How is the growth of the healthcare segment affecting the growth of the cell and gene therapy market? 4. Who are the leading vendors in the cell and gene therapy market, and what are their market shares? 5. Which product type/ end-user type/region is generating the largest revenue in the Asia Pacific region?Read the full report: https://www.reportlinker.com/p05827567/?utm_source=GNW

About ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Link:

The global cell and gene therapy market by revenue is expected to grow at a CAGR of over 30.90% during the period 20192025 - GlobeNewswire

Cochlear implant uses LEDs to tackle hearing loss – Optics.org

04Aug2020

University of Gttingen device points towards more efficient treatments.

Cochlear implants are an established treatment, using a microphone to detect sound and converting that sound into electrical impulses, split into several channels for different frequency ranges. Electrode contacts, typically 12 to 24 in number, then deliver the electrical impulses to the ganglion neurons of the cochlea.

But these devices can offer poor quality sound encoding, partly due to the large lateral spread of electrical current from each electrode, stimulating too many auditory neurons at the same time. A project at the University of Gttingen has now developed a light-based alternative device, reported in Science Translational Medicine.

"The lateral spread is considered the major bottleneck of electrical implants," said Tobias Moser of the University of Gttingnen. "Despite efforts such as multipolar stimulation and current steering, it seems hard or even impossible to overcome."

Neurons are not typically light sensitive, although the growing field of optogenetics has found elegant ways to induce neurons into expressing light-sensitive proteins through genetic modifications in so-called transgenic animals, and making the neurons react to illumination by laser pulse.

Since light can be better confined in space than electric current, optogenetic techniques could allow cochlea stimulation to be made more efficient. However, light sources for optogenetics have usually been individual GaN-based LEDs and optical fibers coupled to external lasers.

In designing an optical cochlear implant (oCI) for auditory treatment and future clinical translation, the Gttingen project had to develop multichannel devices suitable for this very specific purpose.

The eventual design featured a linear array of 10 LED chips, each 270 by 220 microns and emitting at 457 nanometers, integrated onto microfabricated 15-micron-thick polyimide-based carriers with interconnecting lines to address individual LEDs.

Hearing restored

"The linear array of 10 LEDs at the oCI tip was designed with a pitch of 500 or 350 microns," noted the project in its published paper. "In addition, an array with four LEDs containing a temperature sensor integrated beneath the first LED chip enables a precise resistance measurement, and thus allows monitoring of potential temperature increase inside the implant."

Having optimized the design for rodent ears, the project inserted the device into transgenic rats and characterized the oCI's stimulation of the animals' auditory nerves. Comparing the spatial spread of excitation from the LEDs of the oCI to that from electrodes of a conventional electrical implant by monitoring the animal's midbrain allowed the frequency selectivity of the oCI device to be characterized.

In behavioral experiments, the team began with rats with normal hearing and trained them to perform a behavior driven by sound. After deafening the rats, the team implanted the oCI device and found that the animals could still perform the acoustically trained behavior with the aid of the multichannel implant.

According to the project, results showed that use of gene therapy and the optical implant in conjunction led to an improved frequency selectivity compared with the electrical alternative, and future enhancements to both the size of LEDs and the spread of light from each emitter could enhance this parameter further.

Although further work will be needed before clinical trails using the device can start, including more detailed studies of behavioral analysis connected with the technique, the team has founded a spin-out company, OptoGenTech, to potentially assist translation of the gene therapy and oCI combination into a human clinical trial and, eventually, bring it to market.

"This is the first demonstration and characterization of preclinical hearing restoration by a complete multichannel oCI system based on LEDs," commented Moser.

View post:

Cochlear implant uses LEDs to tackle hearing loss - Optics.org

ONCOS-102 and Keytruda: A Pairing That Could Cure Mesothelioma – Mesothelioma Guide

The mesothelioma study weve been waiting for is finally going to happen.

Targovax, the manufacturer of the complex ONCOS-102, is teaming with the maker of the well-known immunotherapy drug Keytruda for a clinical trial. The phase 2 study is explicitly using ONCOS-102 and Keytruda for people with pleural mesothelioma.

The trial, which will enroll up to 100 patients, tests a combination of Keytruda, ONCOS-102 and standard chemotherapy. Targovax, which is based in Norway, said the study will involve United States locations.

The aim is to start enrolling patients into the trial within 12 months, the companys press release reads.

If youre interested in participating, reach out to our medical staff. Our patient advocate Jenna Campagna can help you apply for this or other clinical trials. There is no fee to reach out and explore your treatment options. Please contact her via email at jenna@mesotheliomaguide.com.

Researchers believe combining ONCOS-102 and Keytruda will make each of them more effective as mesothelioma treatments. Both are used to help the immune system fight mesothelioma. The therapies just go about their aid in different ways.

ONCOS-102 is a combination of virotherapy and immunotherapy. Its an adenovirus that transmits immune-stimulating proteins into the body. The adenovirus breaks up the tumor cells, and the proteins signal for help to the T-cells.

When the tumor cells break apart, they release antigens into the disease environment. These antigens serve as fingerprints, which helps T-cells to locate other tumors.

In a recent mesothelioma study, ONCOS-102 was paired with standard chemotherapy. Researchers compared its effects to just using chemotherapy. ONCOS-102 plus chemotherapy showed across-the-board benefits:

Keytruda, the brand name for the immunotherapy drug pembrolizumab, is an immune checkpoint inhibitor. It blocks cancerous proteins that suppress the immune system. Keytruda stops PD-L1 (cancer protein) from communicating with PD-1 (immune system T-cell protein). Doing so allows the T-cells to attack tumors.

Keytruda recently received approval from the U.S. Food and Drug Administration for limited use in treating pleural mesothelioma. The FDA granted permission for cases with a high level of PD-L1 protein expression, as research has shown that Keytruda helps these patients.

The combination of Keytruda and ONCOS-102 makes sense. ONCOS-102s primary goal is to get T-cells into the tumor environment. Keytruda will help those T-cells register mesothelioma cells as dangerous.

Keytruda is the market-leading checkpoint inhibitor and thus our preferred choice of partner, said ystein Soug, the CEO of Targovax. We are hopeful that the combination will lead to improved outcomes for patients with this challenging disease who currently have few treatment alternatives.

Targovax is testing ONCOS-102 with an immunotherapy drug for peritoneal mesothelioma patients as well. The company is hosting a phase 2 clinical trial that combines ONCOS-102 with durvalumab, which is also a PD-L1 inhibitor therapy.

Show Sources & Author

Devin Golden is the content writer for Mesothelioma Guide. He produces mesothelioma-related content on various mediums, including the Mesothelioma Guide website and social media channels. Devin's objective is to translate complex information regarding mesothelioma into informative, easily absorbable content to help patients and their loved ones.

Get in depth knowledge about your diagnosis & the best treatments.

Learn More

See the rest here:

ONCOS-102 and Keytruda: A Pairing That Could Cure Mesothelioma - Mesothelioma Guide

Mesothelioma Compensation Center Urges the Family of a Power Plant Worker with Recently Diagnosed Mesothelioma to Call Attorney Erik Karst of Karst…

HOUSTON, July 29, 2020 /PRNewswire/ -- The Mesothelioma Compensation Center says, "We are appealing to the family of a power plant worker nationwide who has just been diagnosed with mesothelioma to please call 800-714-0303 for direct access to attorney Erik Karst of the law firm of Karst von Oiste. Erik Karst and his colleagues at Karst von Oiste have been assisting power plant workers for decades and they are responsible for over a billion dollars in financial compensation results for people like this.

"Financial compensation for a power plant worker with this rare cancer caused by asbestos exposure might exceed a million dollars-if the person or family hires an experienced mesothelioma lawyer. Erik Karst is one of the nation's leading mesothelioma attorneys-and he will know how to help you or your loved one."www.karstvonoiste.com

The Mesothelioma Compensation Center is also urging the wife or adult son-daughter of a former power plant worker who had heavy to extreme exposure to asbestos at work to please tell their doctors about his work place exposure to asbestos if he has been hospitalized with pneumonia. Mesothelioma and the Coronavirus have similar symptoms such as pneumonia, high fever, and shortness of breath.

They say, "The average age for a person with mesothelioma in the United States is 72 years old. Mesothelioma could easily be misdiagnosed as the Coronavirus. We do not want a person with mesothelioma to not get compensated in 2020 because they were misdiagnosed with the Coronavirus. If your husband or dad is in the hospital right now with pneumonia and you know for a fact he had significant exposure to asbestos at work-before 1982 please call us at 800-714-0303 so we might try to assist in ensuring a proper diagnosis-if possible."https://MesotheliomaCompensationCenter.Com

The Mesothelioma Compensation Center is Extremely Focused on Helping the Following Types of People with Mesothelioma:

For more information about power plants inthe United Statesplease refer to the US Energy Information Agency's website: https://www.eia.gov/ state/maps.php.

The Mesothelioma Compensation Center specializes in assisting specific types of people who have been diagnosed with mesothelioma. The Center's top priority is assisting US Navy Veterans, shipyard workers, oil refinery workers, public-utility workers, chemical plant workers, manufacturing workers, power plant workers, plumbers, welders, electricians, millwrights, pipefitters, boiler technicians, machinists, nuclear power plant workers, hydro-electric workers or oil and gas field production workers who have been diagnosed with this rare cancer caused by asbestos exposure. In most instances a diagnosed person with mesothelioma was exposed to asbestos in the 1950's, 1960's, 1970's, or 1980's.https://MesotheliomaCompensationCenter.Com

According to the CDC the states indicated with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon.

However, a power plant or public utility worker with mesothelioma could live in any state including California, New York, Florida, Texas, Illinois, Kentucky, Tennessee, Mississippi, Georgia, Alabama, Wyoming, Colorado, New Mexico, Nevada, Utah, Arizona, Idaho, or Alaska.www.karstvonoiste.com/

For more information about mesothelioma please refer to the National Institutes of Health's web site related to this rare form of cancer:https://www.cancer.gov/types/mesothelioma.

Media Contact:Michael Thomas800-714-0303241211@email4pr.com

View original content to download multimedia:http://www.prnewswire.com/news-releases/mesothelioma-compensation-center-urges-the-family-of-a-power-plant-worker-with-recently-diagnosed-mesothelioma-to-call-attorney-erik-karst-of-karst-von-oiste-for-his-passion-the-best-client-compensation-results-301101967.html

SOURCE Mesothelioma Compensation Center

Read the original:

Mesothelioma Compensation Center Urges the Family of a Power Plant Worker with Recently Diagnosed Mesothelioma to Call Attorney Erik Karst of Karst...

Alabama US Navy Veterans Mesothelioma Advocate Has Endorsed Attorney Erik Karst of Karst von Oiste To Make Certain a Navy Veteran with Mesothelioma in…

(MENAFN - EIN Presswire)

MONTGOMERY , ALABAMA, USA, August 4, 2020 / EINPresswire.com / -- The Alabama US Navy Veterans Mesothelioma Advocate says, "We have endorsed, and we recommend attorney Erik Karst of the law firm of Karst von Oiste if you are a Navy Veteran with recently diagnosed mesothelioma in Alabama or their family. Erik Karst is one of the nation's leading mesothelioma attorneys and he specializes in financial compensation for US Navy Veterans who have this rare form of cancer caused by asbestos exposure. Financial compensation for a Navy Veteran with mesothelioma might exceed a million dollars. If the Navy Veteran spent a career in the navy the compensation might be in the millions. For direct access to attorney Erik Karst of Karst von Oiste please call 800-714-0303 anytime." [To enable links contact MENAFN]

The Advocate is also appealing to the wife, or adult son-daughter of a Navy Veteran with mesothelioma in Alabama to call Erik Karst of Karst von Oiste at 800-714-0303 to assist in building the foundation for the veteran's mesothelioma claim. There are Internet ads that suggest, 'no lawsuits' needed which is a stretch of the truth. In reality-if a Navy Veteran with mesothelioma or their family hires a local car accident attorney the Veteran or their family might get significantly shortchanged-out of hundreds of thousands of dollars or more. Rather than roll the dice on financial compensation for a Navy Veteran with mesothelioma please call 800-714-0303 for direct access to attorney Erik Karst of Karst von Oiste. [To enable links contact MENAFN]

The US Navy Veterans Mesothelioma Advocate offers their free services to US Navy Veterans with mesothelioma in Birmingham, Montgomery, Mobile, Huntsville, Tuscaloosa or anywhere in Alabama. [To enable links contact MENAFN]

For the best possible treatment options in Alabama the Alabama US Navy Veterans Mesothelioma Advocate strongly recommends the following heath care facility with the offer to help a diagnosed Veteran, or their family get to the right physicians at these hospitals.

The University of Alabama's Comprehensive Cancer Center in Birmingham. [To enable links contact MENAFN] .

About one third of all US citizens diagnosed with mesothelioma each year are Veterans of the US Navy. Before a Navy Veteran with mesothelioma or their family retain the services of a lawyer or law firm, they are urged to call the US Navy Veterans Mesothelioma Advocate anytime at 800-714-0303. [To enable links contact MENAFN]

The states with the highest incidence of mesothelioma include Maine, Massachusetts, Connecticut, Maryland, New Jersey, Pennsylvania, Ohio, West Virginia, Virginia, Michigan, Illinois, Minnesota, Louisiana, Washington, and Oregon.

However, based on the calls the US Navy Veterans Mesothelioma advocate receives a US Navy Veteran diagnosed with mesothelioma could live in any state including New York, Florida, California, Texas, New Hampshire, Vermont, Iowa, Indiana, Missouri, Kentucky, Tennessee, North Carolina, Georgia, Alabama, Mississippi, Oklahoma, Arkansas, Nebraska, North Dakota, Montana, Wyoming, Nevada, New Mexico, Utah, Arizona, Idaho, or Alaska. [To enable links contact MENAFN]

For a listing of various classes of US Navy ships or submarines please visit the US Navy website on this topic: [To enable links contact MENAFN] .

For more information about mesothelioma please refer to the National Institutes of Health's web site related to this rare form of cancer: [To enable links contact MENAFN] .

Michael ThomasAlabama US Navy Veterans Mesothelioma Advocate+1 800-714-0303email us here

See the original post here:

Alabama US Navy Veterans Mesothelioma Advocate Has Endorsed Attorney Erik Karst of Karst von Oiste To Make Certain a Navy Veteran with Mesothelioma in...

Mesothelioma treatment Market Insight And Key Players With Forecasts Up To 2028 – WOLE TV

Global Mesothelioma treatment Market presents an in-depth review and technical research, with useful facts and figures, of the current and future state of the mesothelioma treatment market worldwide. mesothelioma treatment market provides information on emerging market opportunities and business factors, developments and evolving technologies that will fuel these growth trends. The report provides a comprehensive overview including Comparison of Definitions, Range, Use, Production and CAGR (percent), Form Segmentation, Share, Revenue Status and Outlook, Capacity, Demand, Market Drivers, Production Status, and Outlook and Opportunities, Export, Import, Growth Rate for Emerging Markets / Countries. The study provides a 360-degree overview of the industrys competitive landscape. The industry study on mesothelioma treatment assesses the main regions (countries) promising a huge market share for the 2016-2028 forecast period.

The market research study on mesothelioma treatment was collected through comprehensive primary research through interviews, surveys, and findings of experienced analysts and secondary research. The study also provides a complete qualitative and quantitative assessment by analyzing data obtained from industry analysts and market participants from mesothelioma treatment around key points in the value chain of the industry.

The regional analysis of this report covers the following regions- Eli Lilly and Company, AstraZeneca, F. Hoffmann-La Roche Ltd, Pfizer Inc., Ono Pharmaceutical Co. Ltd, Bayer AG, Teva Pharmaceuticals Industries Ltd.

Get Sample Copy of The Report @ https://www.quincemarketinsights.com/request-sample-68793?utm_source=Kalpesh&utm_medium=WTV

Useful findings of this research are-

-Study of historical data.

-Analysis of existing scenarios in every domestic and national sector.

-Study of patterns, accessible knowledge and data figures.

-Use of validated project methods for the next five years.

Statistical analysis, figures and prime data included in the report contains-

-Market size (current and projected for the last few years)

-Market share analysis as per different companies)

-Market forecast)

-Demand)

-Price analysis)

-Market contributions (Size, Share according to geographical boundaries)

The report benefits Market Investigators, companies, Vendors, Buyers, Suppliers, Individual professionals and Competitive organizations

Make An Enquiry Before Purchasing Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-68793?utm_source=Kalpesh&utm_medium=WTV

Market Segmentation:

ByTreatment Type:

By Route of Administration:

ByDistribution Channel:

By End User:

By Region:

North AmericaMesothelioma treatment market

EuropeMesothelioma treatment market

Asia PacificMesothelioma treatment market

Middle East & AfricaMesothelioma treatment market

South AmericaMesothelioma treatment market

Contact:Quince Market InsightsOffice No-A109Pune, Maharashtra 411028Phone: +91-9850603687/7972869557Email: sales@quincemarketinsights.comWeb: http://www.quincemarketinsights.com

About :QMI has the most comprehensive collection of market research products and services available on the web. Deliver reports from almost all major publications and update the list on a regular basis with instant online access to the worlds broadest and most up-to-date archive of expert insights on global markets, companies, products and patterns.

Read the original post:

Mesothelioma treatment Market Insight And Key Players With Forecasts Up To 2028 - WOLE TV

Compensation claim after ICI worker’s asbestos-related death – Runcorn and Widnes World

THE death of a loving grandfather from an asbestos-related lung cancer has led to his family launching a compensation claim.

Sandiway native Christopher Lees worked for ICI in Northwich and Runcorn for close to 40 years, after leaving school in 1955 until his retirement in the early 1990s.

In February, he was diagnosed with mesothelioma an aggressive and terminal lung cancer caused by breathing in asbestos dust and fibres and sadly passed away on May 17 aged 79.

A father of two daughters and grandfather of four, Christopher was also the main carer for his wife, Gillian, who has a lung condition and severe arthritis.

He was a regular and respected church goer, but his family were unable to give him a proper funeral because of coronavirus restrictions.

Despite this and the severely restricted numbers allowed at his burial, that did not stop his family, friends and parishioners from lining the funeral route on the day to send him off.

It is believed that he was exposed to asbestos while working at ICI in Winnington and the companys Castner Kellner site in Runcorn.

Nicola Johnson, Christophers daughter, said: In just six months, dad went from helping me with the school run and being Mums fulltime carer to not being here at all.

He just deteriorated so fast and was in a huge amount of pain constantly at the end.

I remember taking him to get the results of his biopsy. We sat there holding hands, both expecting bad news, as we didnt think wed be lucky enough to get away with it. Devastatingly, we were right.

He was really upset and so scared in the car on the journey home. He told me what his wishes were and how we were going to cope with it."

Christopher receiving his 20-year service award

We were told he could have chemotherapy to extend his life, and for the next two weeks hed pick himself up and push himself to go out for walks to keep himself fit to be ready to face what was coming next.

Then Covid-19 hit, and all bets were off.

Birchall Blackburn Law is helping Christophers family make an industrial disease compensation claim and is seeking the memories and recollections from former ICI employees.

Christopher started in the research and development department and from 1968 to 1975 worked on the development of Monnex, which required him to wear an asbestos suit.

In 1975 Christopher moved to ICIs Castner Kellner site to work as a safety advisor, improving working conditions and reducing the risk of accidents and injuries.

In 1988/89 Christopher returned to work at Winnington and Lostock sites as a safety advisor.

Victoria Roberts, an industrial disease specialist solicitor at Birchall Blackburn Law, said: Mesothelioma is a cruel lung cancer that takes decades to develop after exposure to asbestos dust and fibres.

It can be difficult to find evidence about where exactly the exposure took place, which is why we need the help of former ICI employees who worked in Northwich and Runcorn.

We would be interested to hear from anyone who worked in the research and development department at Winnington and might be able to assist with a description of the fire suits used, as well as anyone who worked at Castner Kellner and can provide information about the maintenance procedure and the use and presence of asbestos on site.

Anyone who knows about the presence of asbestos at ICI in Northwich and Castner Kellner in Runcorn is asked to call Victoria confidentially on 01244 688763 or email varoberts@birchallblackburn.co.uk

See the original post:

Compensation claim after ICI worker's asbestos-related death - Runcorn and Widnes World

The 5 Possibilities For Life On Mars – Forbes

While Mars is known as a frozen, red planet today, it has all the evidence we could ask for of a ... [+] watery past, lasting for approximately the first 1.5 billion years of the Solar System. Could it have been Earth-like, even to the point of having had life on it, for the first third of our Solar System's history?

For as long as humanity has been watching the skies, weve been fascinated with the possibility that other worlds much like Earth might contain living organisms. While our visits to the Moon taught us that its completely barren and uninhabited, other worlds within our Solar System remain full of potential. Venus might have life in its cloud-tops. Europa and Enceladus might have life teeming in a sub-surface ocean of liquid water. Even Titans liquid hydrocarbon lakes provide a fascinating place to search for exotic living organisms.

But by far, the most fascinating possibility is the red planet: Mars. This smaller, colder, more distant cousin of Earth most certainly had a wet past, where liquid water clearly flowed on the surface for more than a billion years. Circumstantial evidence has pointed to the plausibility of life on Mars, not only in the ancient past, but possibly still living, and perhaps occasionally active, even today. There are five possibilities for life on Mars. Heres what we know so far.

Oxbow bends only occur in the final stages of a slowly flowing river's life, and this one is found ... [+] on Mars. While many of Mars's channel-like features originate from a glacial past, there is ample evidence of a history of liquid water on the surface, such as this dried-up riverbed.

With the information weve obtained from various orbiters, landers, and rovers, weve made a slew of fascinating discoveries on Mars. We see dried-up riverbeds and evidence of ancient glacial events on the Martian surface. We find tiny hematite spheres on Mars as well as copious evidence for sedimentary rock, both of which only form on Earth in aqueous environments. And weve observed solid sub-surface ice, snows, and even frozen surface water on Mars in real-time.

Weve even observed whats likely to be briny surface water actively flowing down the walls of various craters, although that result is still controversial. All the raw ingredients that are required for life on Earth were abundant on early Mars as well, including a thick atmosphere and liquid water on its surface. Although Mars no longer appears as though its teeming with life today, there are three pieces of evidence that past or even present life might be a possibility.

The hematite spheres (or 'Martian blueberries') as imaged by the Mars Exploration Rover. These are ... [+] almost certainly evidence of past liquid water on Mars, and possibly of past life. NASA scientists must be certain that this site -- and this planet -- are not contaminated by the very act of our observing. As of yet, there is no surefire evidence for either past or present Martian life.

The first compelling piece of evidence came from the instruments on board NASAs Mars Viking landers in 1976. There were three biology experiments performed: a gas exchange experiment, a labeled release experiment, and a pyrolytic release experiment, followed-up by a gas chromatograph mass spectrometer experiment. The labeled release experiment yielded a positive result when performed on both Viking landers, but only the first time the test occurred. All other experiments came back negative.

The second piece of evidence came when a fragment of a Martian meteorite Allan Hills 84001 was recovered on December 27, 1984. As it turns out, approximately 3% of all meteorites that fall to Earth originate from Mars, but this one was particularly large: nearly 2 kilograms (over 4 pounds) heavy. It originally formed on Mars some 4 billion years ago, and landed on Earth only some 13,000 years ago. When we looked inside of it in 1996, it appears to contain material that could be the remnants of fossilized organic life forms, although they could have arisen from inorganic processes as well.

Most recently, the Mars Curiosity rover detected Methane vents on Mars, which could have been ... [+] produced either organically or inorganically. If it's organics, the author will lose a bet with physicist Robert Garisto!

And finally, the third piece of evidence came out with NASAs latest Mars rover: Curiosity. As the seasons changed on Mars, Curiosity detected burps of methane emitted from specific underground locations, but only at the end of Martian winter and with the onset of spring. This is, again, an ambiguous signal at best, as inorganic, geochemical processes could be seasonal and result in the release of methane, but organic, biological processes could cause this as well.

When we look at the full suite of evidence at everything weve learned about Mars there are five possibilities for the history of life on the Red Planet. It could be an eternally barren world; it could be a world where life thrived for a time but then hit a dead-end; it could have extant life on it today; it could have been seeded by Earth life early on; or it could only have Earth-based organisms that made their way there since the dawn of the space age.

Heres what each possibility would mean.

Mars, along with its thin atmosphere, as photographed from the Viking orbiter. From afar as well as ... [+] up close, there are no obvious, compelling signs of past or present life on the planet, although there are some ambiguous points that could either favor or disfavor life.

1.) Mars never had life on it. Despite having the same raw ingredients as early Earth and similar, watery conditions, the necessary circumstances that enable life to form simply never occurred on Mars. All the geological and chemical processes that occur inorganically still happened, but nothing organic. Then, a little more than three billion years ago, Marss atmosphere was stripped away by the Sun, drying up any liquid surface water and leading to Marss current appearance.

This is the most conservative stance, and would require that all three of the purported positive tests have either an inorganic or contamination-based resolution. This is eminently possible, and remains in the mind of many the default assumption. Until some very compelling evidence comes along that robustly points to either past or present life on Mars, this will likely remain the leading hypothesis.

Seasonal frozen lakes appear throughout Mars, showing evidence of (not liquid) water on the surface. ... [+] These are just a few of the many lines of evidence that point to a watery past on Mars. Whether water indicates life or not has not yet been determined.

2.) Mars had life early on, but it died out. This scenario, in many ways, is just as compelling as the prior one. Its very easy to imagine that a world with:

could lead to life. To many, its virtually impossible to imagine that these conditions after more than a billion years wouldnt lead to life, considering that life arose on Earth no more than a few hundred million years after its formation.

However, the loss of the Martian atmosphere had a profound effect on the planet, and could have resulted in the extinction of all life on Mars. Drilling down into the sedimentary rock of Mars and searching for fossilized life forms, or even metamorphosed carbon-rich inclusions, could potentially reveal the evidence necessary to validate this scenario.

Recurring slope lineae, like this one on the south-facing slope of a crater on the floor of Melas ... [+] Chasma, have not only been shown to grow over time and then fade away as the martian landscape fills them in with dust, but are known to be caused by the flowing of briny, liquid water. Perhaps, in those flows, life processes are occurring.

3.) Mars had early life, and it still persists in a mostly-dormant form beneath the surface. This is the most optimistic, but still scientifically viable, view of life on Mars. Perhaps life took hold early on, and when Mars lost its atmosphere, a few extremophiles remained in a sort of frozen, suspended-animation state. When the right conditions emerged perhaps underground, where liquid water can occasionally flow that life wakes up and begins performing its critical biological functions.

If this is the case, then there are still organisms to be found beneath the Martian surface, perhaps in the shallow sands just a few feet or even mere inches below our spacecraft. Were likely only talking about single-celled life, perhaps not even reaching the complexity of a eukaryotic cell, but life on any world other than Earth would still be a revolution for science. NASAs Perseverance rover, which launched successfully on July 30, 2020, will collect critical soil samples to attempt to test this hypothetical scenario.

A planetoid colliding with Earth, larger than even the asteroid strike that wiped out the dinosaurs, ... [+] could easily kick up sufficient amounts of material that some of it would make it to Mars, possibly contaminating the ancient Red Planet with Earth-like material, as well as Earth-based biological organisms.

4.) Mars didnt have life until Earth seeded it, naturally. 65 million years ago, a very large, fast-moving body impacted Earth, creating Chixulub crater and kicking up enough material to blanket the Earth in a cloud of debris, leading to the fifth great mass extinction in Earths history. And, like many massive impacts, this one likely kicked up small pieces of Earth all the way into space, the same way that impactors on the Moon or Mars send meteors throughout the Solar System, where some of them eventually land on Earth.

Well, a few impacts likely go the other way as well: sending Earth-borne material to other worlds, including Mars. It seems unreasonable that the material in Earths crust, rich in organic life, wouldnt make it to Mars at all. Instead, its eminently plausible that Earth-based organisms made it to Mars and began reproducing there, whether they thrived or not. Perhaps someday, well be able to know the full history of life on Mars, and determine whether any of it has the same common ancestor that all extant Earth life is descended from. Its a fascinating possibility that isnt easy to dismiss.

The first truly successful landers, Viking 1 and 2, returned data and images for years, including ... [+] providing a controversial signal that may have indicated life's presence on the red planet.

5.) Our modern space program spread Earth-based life to Mars. And, finally, perhaps Mars truly was a barren, lifeless planet at least for billions of years until the dawn of the space age. Perhaps spaceborne materials that werent 100% decontaminated or sterilized landed on the Martian surface, bringing modern Earth organisms with them as stowaways.

Its the ultimate nightmare of astrobiologists: that theres a fascinating history of life to uncover on another world, but well contaminate it with our own organisms before we ever learn the true history of life on that world. In the worst case scenario, it could be the case that was surviving simple life on Mars of Martian origin, but that Earth life arrived and out-competed it, driving it to a rapid extinction. This very real, healthy fear is why were frequently so conservative, from a biological perspective, when we explore other planets and foreign worlds.

An Atlas V rocket with NASA's Perseverance Mars rover launches from pad 41 at Cape Canaveral Air ... [+] Force Station. The Mars 2020 mission plans to land the Perseverance rover on the Red Planet in February 2021, where it will seek signs of ancient life and collect rock and soil samples for possible return to Earth. (Paul Hennessy/SOPA Images/LightRocket via Getty Images)

There is a tremendous hope that current and future generations of Mars rovers and orbiters will help us finally puzzle out whether Mars either now or at any point in its past has ever harbored life. If the answer to that question is affirmative, then it leads to an important follow-up question: is that life related to or independent of life on Earth? It is possible that life originated on Earth and seeded Mars with life; its possible that life originated on Mars and then seeded Earth; its even possible that life predated both Earth and Mars, and early forms of it took hold on both planets.

But at this point in time, we have no overwhelming evidence that life ever existed on Mars at all. We have a few hints that could be indicators of past or present life there, but entirely inorganic processes could explain each and every one of those observed results.

As always, the only way well find out the truth is by conducting more and better science with superior instruments and techniques. As NASAs Perseverance rover moves ahead to collect a variety of soil samples, the next step will be returning them to Earth for laboratory analysis. If we succeed at that, we could know for certain, within the next decade, which of these five possibilities is most consistent with the truth about Mars.

See the original post here:

The 5 Possibilities For Life On Mars - Forbes

As three probes head for Mars, Curiosity nears eighth anniversary on red planet – Astronomy Now Online

With three probes on their way to Mars, NASAs Curiosity rover will celebrate its eighth year on Mars 6 August as it continues to explore the lower regions of Mount Sharp in Gale Crater. This frame from a panorama captured on 13 October 2019 shows Mount Sharp in morning sunlight. Click on the image to view the entire panorama and click again for the full high-resolution view, scrolling as needed to take it all in. Curiosity landed on Mars in 2012 and has collected data showing the environment in Gale Crater, at least, was habitable in the distant past. NASAs Perseverance rover will land in Jezero Crater next February to search for signs of past microbial life. The Hope orbiter, built by the United Arab Emirates and currently on its way to Mars, will slip into orbit that same month as will Chinas Tianwen-1 probe. The Chinese mission features an orbiter and a rover, which is expected to descend to the surface a few months after arrival.

Read more here:

As three probes head for Mars, Curiosity nears eighth anniversary on red planet - Astronomy Now Online

Teijin Aramid on the way to Mars – EPPM

Teijin Aramid, a world leader in aramid, announces that, with the successful launch of NASAs Mars Perseverance Rover from Cape Canaveral in Florida, its Technora high-performance fibre is again enabling space exploration.

The premium para-aramid Technora plays a critical role in the structure of the Rovers landing parachute, developed by Airborne Systems and NASAs Jet Propulsion Laboratory, which will be deployed during descent to Mars in February 2021.

On a mission to seek signs of past microscopic Martian life, the Mars Perseverance Rover is carrying the heaviest payload of any mission to the Red Planet.

The parachute system has undergone an extensive set of demanding tests, proving it can support an inflation load of 31,751kg.

To ensure the unique parachute system performs under the extreme conditions, 60kg of Technora are incorporated into the suspension cords. Technora is also used in the parachute riser. This mission builds on the proven technologies and systems of previous Mars Rover expeditions which also carried Technora including on the Mars Curiosity Rover in 2012.

Charles Lowry, Lead Project Engineer for Airborne Systems North America, Mars 2020 Parachute System Subcontractor, said: When designing and building the parachute system for the Mars Perseverance Rover, it was very important to utilise the volume that we were allocated to its fullest potential. Thanks to its outstanding strength-to-weight ratio, Technora allows us to do just that and increases the overall safety of the mission by providing more volume for stronger parachute cloth. There are many unknowns involved in any mission to space, but the tried and proven performance of Technora is not one of them.

Peter ter Horst, CEO Teijin Aramid, added: Today is a proud day for everyone at Teijin Aramid. Our journey into space has taken another exciting step. Our partners throughout the space industry have long recognised the unique potential of incorporating Technora into their products to unlock new levels of performance. The launch of the Mars Perseverance Rover shows that were again the partner of choice when strength and reliability are of unprecedented importance.

See original here:

Teijin Aramid on the way to Mars - EPPM

Destiny 2 is getting rid of Mars this fall, so one player recreated it in Garry’s Mod – GamesRadar+

With Destiny 2 moving Mars along with four other destinations to the Destiny Content Vault on November 10 with the release of Beyond Light, one player has taken it upon themselves to preserve the red planet in the Garry's Mod Hammer Editor.

Reddit user Quantum086 recently shared their recreation after a month of work (and roughly 200 hours) in the map maker. "When I heard Mars was going away, I knew I had to save my favorite destination somehow," they said, "so I built the main Braytech Futurescape area, from the rail system to where the lost sector starts."

You can view and download the full map over on the Steam Workshop. Quantum originally wanted to remake all of Mars, but ended up focusing on the northern half due to object limitations in the map maker itself. They also had to cut a lot of the Hive corruption around the Braytech facility due to asset restraints. Even so, the sheer size of the map is staggering, to say nothing of the commitment to detail.

As the build's Steam screenshots show, Quantum included everything from large construction equipment to tiny light fixtures. Their recreation is covered in boxes, machinery, pipes, tanks, and countless other odds and ends that really sell the Mars landscape.

For fun, I hopped into Destiny 2 to frame some side-by-side comparisons of Quantum's recreation, and this makes the map look even more amazing:

Head here for more on the content going into and coming out of the Destiny Content Vault.

Read more here:

Destiny 2 is getting rid of Mars this fall, so one player recreated it in Garry's Mod - GamesRadar+

Testosterone Replacement Therapy Market 2020 Segments Analysis: Companies Bayer HealthCare Pharmaceuticals, Sandoz, Clarus Therapeutics, TesoRx -…

The Global Testosterone Replacement Therapy Market Report enfolds a comprehensive analysis and assessment of the global Testosterone Replacement Therapy market. The report mainly intends to help market players and clients to understand the market in terms of structure, scope, profitability, attractiveness, and growth possibilities. The report also highlights a detailed review of market segmentation, potentials, emerging trends, and volatilities in the global Testosterone Replacement Therapy market.

Also, precise evaluation of market revenue, sales volume, global demand, and production is covered in the global Testosterone Replacement Therapy market report. The report further illuminates a thorough assessment of market competition, major market players, and the global Testosterone Replacement Therapy industry environment. It also underscores crucial market dynamics, pricing trends, demand-supply proportions, growth-driving forces, market restraining factors, and limitations in the global Testosterone Replacement Therapy market these poses a direct impact on the development of the market.

Sample Copy Global Testosterone Replacement Therapy Market Report 2020

Assessment of leading Testosterone Replacement Therapy market participants:

The market ruining disaster of COVID-19 has been severely affecting all fields of the global economy as well as the global Testosterone Replacement Therapy market. The pandemic has disrupted well-ordered market operations across the world. Though, the global Testosterone Replacement Therapy market is expected to reach projected CAGR during the forecast period as rising technological development, product innovations, and rapid industrializations are likely to boost market development in the near future. Also, soaring Testosterone Replacement Therapy demand, raw material affluence, adept infrastructures, and product awareness are uplifting the Testosterone Replacement Therapy market growth.

The leading companies are operating in the Testosterone Replacement Therapy industry at global and regional levels to cater to the rising demand for the Testosterone Replacement Therapy . The companies also execute various product research, innovation, development, and technology adoptions to offer better fit products in the market. The report examines all their efforts alongside business strategies, which include product launches, brand promotions, mergers, acquisitions, amalgamations, and ventures.

Companies production bases, capacities, manufacturing volume, product specifications, raw material, concentration rate, cost analysis, major vendors, global presence, distribution networks, serving segments, and effective production processes are evaluated in the report that offers the detailed notion of each companys organizational structure.

Study of major segments of the global Testosterone Replacement Therapy industry:

Coherent survey of Global Testosterone Replacement Therapy Market 2020

Significantly, the report reviews their financial status by assessing gross margin, profit, sales volume, production cost, pricing structure, revenue, and growth rate. The referred analysis prompted other market contenders and investors to comprehend the strengths, weaknesses, and market positions of their rivals.

Major Highlights of the Report:

Market Research Exploreprovides customization of reports as per your need. Get in touch with our sales team at[emailprotected], if you want to personalize the report to meet your requirements.

Read this article:
Testosterone Replacement Therapy Market 2020 Segments Analysis: Companies Bayer HealthCare Pharmaceuticals, Sandoz, Clarus Therapeutics, TesoRx -...

The GOP Needs to Hit Rock Bottom – The Bulwark

The last thing I want to do is offend my friend David French, who is one of the most admirable voices in America today. Nor, finding myself in the highly unusual position of disagreeing with him, do I want to pile on, since my colleague Charlie Sykes has already penned a response that is characteristically robust. But the question of how conservatives should vote in Novemberwhether to punish the entire Republican party by voting straight-ticket Democrat, or merely vote against Trumpis important and needs further airing.

David argues that conservatives need not vote against Republican Senate candidates in order to send a message:

A rage, fury, and a burn it all down mentality is one of the maladies that brought us to the present moment. Repeating that same impulse, but with an entire party in the crosshairs, will only compound our political dysfunction.

This assumes that the reason some plan to evict Republican senators is simply a matter of anger. French uses the word vengeance. But voting against a candidate or even a whole party is not nihilism. Its not burning it all down. Its the legal, constitutional way to express approval or disapproval. The current Republican party has itself chosen to become the arsonist party. It has decided to go along with undermining faith in institutions, shredding norms, elevating conspiracy theories, disregarding laws, and tossing aside truth whenever the leader dictates. The most demoralizing aspect of the past four years has not been that a boob conman was elected president but that one of the two great political parties surrendered to him utterly.

David suggests that voting against Republican senators is completely devoid of grace. It ignores the monumental pressures that Donald Trump has placed on the entire GOP and the lack of good options that so many GOP officeholders faced.

Its certainly true that Republicans perceived their options to be limited. How many times have they confided, behind closed doors, that they deplore Trumps conduct, but explain that their hands are tied? If they speak up, they say, they will flush their careers down the drain. Look at what happened to Jeff Flake, Mark Sanford, and Bob Corker!

But this overstates things. A number of Republicans have stood up to Trump and maintained their electoral viabilityespecially when they challenged him on matters that he has shown little interest in, namely public policy. Sen. Pat Toomey for example, voted against the presidents USMCA trade agreement and (gasp) wrote an op-ed in the Wall Street Journal explaining his reasoning.

It is the only trade pact ever meant to diminish trade. Since Naftas implementation, American exports to Mexico have grown more than fivefold. But imports grew even more, widening the trade deficit. The Trump administration finds this unacceptable, even though the trade deficit is mostly meaningless. Hence USMCA has a myriad of provisions to warm the hearts of protectionists.

When the president abruptly announced, following a phone call with Turkish leader Recep Erdoan, that he was withdrawing American troops forthwith from Syria, a number of Republicans voiced horror. Sen. Ben Sasse said it would lead to a slaughter. Sen. Ted Cruz said it would be DISGRACEFUL if we sat idly by while Turkey slaughters the Kurds, as public reports suggest that Turkish leader Erdogan explicitly told President Trump he intends to do. Rep. Liz Cheney called it a catastrophic mistake that puts our gains against ISIS at risk and threatens Americas national security. Sens. Lindsey Graham, Mitch McConnell, Mitt Romney, and Marco Rubio, former U.N. ambassador Nikki Haley, and others weighed in as well.

When the president suggested lifting sanctions on Russia, Sen. Rob Portman said it would be horrible for the United States. And after Gen. James Mattis wrote an op-ed saying that Donald Trump was making a mockery of the U.S. Constitution, Sen. Lisa Murkowski said, I was really thankful. I thought General Mattiss words were true, and honest and necessary and overdue.

So, it is possible to speak up about this president and survive. I use that word advisedly, because these Republican office holders often use words like kill or destroy or annihilate when contemplating what Trump would do to them if they raise their heads too far above the parapet. In fact, all that actually threatened them was the possibility of nasty tweets and the chance that they might lose their seats.

David French writes:

If you think its obvious what they should have done, how many readers have faced such a choice: take a tough stand and likely lose your lifes work or muddle through and hope to emerge on the other side with your dignity and conscience intact? If you faced such a choice, did you take the stand and bear the cost?

David is right that very few people in any walk of life display courage on anything, though craven Republicans holding House and Senate posts might want to pause from time to time to contemplate the extraordinary valor of protesters in Hong Kong, Iran, and Egypt who continue to put their freedom and sometimes their lives at risk by taking to the streets. And before we extend too much grace to Republican office holders, we need to ask: Should being an elected official really be ones life work? And must one cling to it even when it requires delegitimizing the very ideas that brought you into politics?

As noted above, Republicans have criticized the president on policy matters, sometimes even harshly. Where they have shrunk into their shells was on matters that are even more critical to the health of our republic. They have, by their silence, given assent to his cruelty, his assaults on truth, his dangerous flirtations with political violence, and his consistent demolition of institutions.

Institutions are like scaffolding. When a societys institutions are weakened, the whole edifice can come crashing down. This often happens to countries as a consequence of war or natural disasters. In our case, it was self-inflicted before the natural disaster (coronavirus) struck, and now, as masonry hits the pavement and floors sag, we are seeing the results.

Donald Trump undermined the institution of the free press, urging his followers to disbelieve everything except what came from the leader. And Republicans were silent. He weakened respect for law enforcement and the courts, suggesting that he was the victim of a deep state and that so-called judges need not be respected. And Republicans were silent. He enriched himself and his family. And Republicans were silent. He introduced doubt about accepting the results of elections. He scorned allies and toadied to dictators. And Republicans were silent. He ran the executive branch like a gangster, demanding personal loyalty and abusing officials, like the hapless Jeff Sessions, who merely followed ethics rules. He ignored the law to get his way on the border wall. Silence again. He violated the most sacred norms of a multi-ethnic society by encouraging racial hatred. Crickets. He made the United States guilty of separating babies from their mothers. And Republicans were silent. He undercut the credibility and honor of the Republican party by failing to dissociate it from kooks and criminals. And Republicans were silent.

Elected officials, terrified of their own constituents, have cowered and temporized in the face of a truly unprecedented assault on democratic values. They believed that they were powerless and acted accordingly. Since they were powerless when it counted, what difference would it make if voters were to make it official?

Consider something else that Sen. Murkowski said in response to Gen. Mattis. When I saw General Mattis comments yesterday I felt like perhaps we are getting to a point where we can be more honest with the concerns that we might hold internally and have the courage of our own convictions to speak up.

When one person shows courage, others are emboldened. If more Republicans had shown a willingness to stand for basic political hygiene, for elemental human decency earlier in this awful era, it might have become contagious.

But since that did not happen, the only thing that will send a message to the Republican party commensurate with its moral abdication over the past four years is to lose in a landslide. Not just Trump, but his silent enablers too.

Read more:

The GOP Needs to Hit Rock Bottom - The Bulwark

Nifty-Fifty All Over Again? Why Investors Should Fear Big Tech Rally – CCN.com

Following the U.S. stock market crash of March, Amazon (NASDAQ:AMZN), Alphabet (NASDAQ:GOOGL), Facebook (NASDAQ:FB), Apple (NASDAQ:MSFT) and Microsoft (NASDAQ:MSFT) combined have added $2.7 trillion to their market cap.

Meanwhile, the stock markets disconnect with the real economy has gotten worse.

While U.S. GDP has lost $2 trillion, the stock market has added $4 trillion to the total market cap of companies in the S&P 500.

Of course, the Federal Reserves balance sheet explosion has aided the stock market rally since March.

The Feds balance sheet expansion has been a common factor in the tech giants rallies since March. These tech companies, along with Tesla (NASDAQ:TSLA), have carried the stock market higher over the past four months.

As the economy suffered under government lockdown orders, the big tech giants were in prime position to smash earnings expectations in Q2.

Apple shares rallied more than 10% to make new all-time highs after reporting sales growth of 11% in Q2 2020 results. Last weeks rally allowed Apple to overtake Saudi Aramco as the worlds most valuable company.

Amazons second-quarter saw the companys sales take off despite the coronavirus pandemic-induced slowdown. Its shares rallied post-earnings before undergoing a bit of profit booking.

Meanwhile, Facebook reported revenue growth of 11% despite an ad boycott from various companies. Its shares gapped up almost 7% post-earnings before a mild selloff.

Alphabet rallied 38% from the March low. After reporting an unprecedented revenue decline, its shares declined post-earnings.

High expectations from Microsoft made the stock rally 25% from the March lows. After reporting spectacular earnings, the stock continued its uptrend.

While Facebook, Amazon, Alphabet, Microsoft, and Apple have returned 35% in 2020, the remaining 495 stocks in the S&P 500 are in the red.

These giants have carried the stock market on their shoulders; if any one of them drops abruptly, the whole market could enter a downward spiral.

Because of this, analysts at Morgan Stanley have predicted a 10% selloff in the U.S. stock market.

If the prediction comes true, the selloff would be reminiscent ofwhat happened to the Nifty-Fifty stocks back in the 1970s. Nifty-Fifty refers to the group of 50 stocks that led the markets toall-time highs in the early 1970s, followed by a 46% crash.

While these stocks had led the rallies to the top, they also led the nosedive that followed.

Back then, Forbes wrote,

The Nifty-Fifty were taken out and shot one by one.

Could the same happen to the tech giants driving the market rally in 2020?

Disclaimer: This article represents the authors opinion and should not be considered investment or trading advice from CCN.com. Unless otherwise noted, the author holds no investment position in the above-mentioned securities.

Read more:

Nifty-Fifty All Over Again? Why Investors Should Fear Big Tech Rally - CCN.com

Why Big Tech Is Colliding With Washington – Foreign Policy

Here is todays Foreign Policy brief: The U.S.House Judiciary Committee plans to grill Big Tech leaders on antitrust, Taliban leaders announce a three-day cease-fire, and working level U.S.-Russian nuclear talks begin in Vienna.

If you would like to receive Morning Brief in your inbox every weekday, please sign up here.

Big Techs (Virtual) Showdown

At noon today in Washington, four of the worlds most powerful tech leaders will testify before a U.S. Congressional committee investigating whether their companies have become too dominant in their respective markets. The CEOs of Amazon, Apple, Facebook, and Google will all testify via video conference. It will be Amazon CEO Jeff Bezoss first time appearing before Congress.

The hearing has been called by the antitrust panel of the House Judiciary Committee and is part of a year-long investigation into possible monopolistic practices of the tech giants as Chairman David Cicilline, a Democrat, attempts to build a case for updating current U.S. antitrust laws.

Appitol Hill. All four companies are immensely profitable, and any effort to break them up or impose onerous regulations will be fought aggressively by a sector becoming more and more at home in Washington. Since 2014, the amount Amazon has spent lobbying the U.S. government has more than tripled and overtook the spending of AlphabetGoogles parent companyin 2019.

What theyll say. Despite user bases in the billions, expect each tech leader to play down their companys dominance (and in Mark Zuckerbergs case, talk up TikToks competitor status). Although the hearing is ostensibly about antitrust, expect Republican lawmakers to bring up perceived censorshipofconservativeviews on web platforms and Democrats to raise concerns about disinformation headed into the U.S. presidential election.

What Were Following Today

Taliban calls cease-fire. The Taliban has announced a three-day cease-fire during the Islamic holiday of Eid al-Adha, with the suspension of hostilities scheduled to begin this Friday. Separately, Afghan President Ashraf Ghani has suggested peace talks are imminent, based on his government nearing an agreed number of prisoner releases. With this action, we look forward to the start of direct negotiations with the Taliban in a weeks time, Ghani said. The decision comes as U.S. special envoy Zalmay Khalilzad is due to visit Afghanistan this week.

Russian and U.S. officials meet for nuclear talks. Working groups of government experts from Russia and the United States meet in Vienna today to begin three days of talks on the topic of nuclear arms control ahead of the expiry of the New START agreement. The meetings follow negotiations between U.S. arms control envoy Marshall Billingslea and Russian Deputy Foreign Minister Sergei Ryabkov in June.

U.S. admits to killing civilian in Somalia. U.S. Africa Command (Africom) has admitted to killing one civilian and injuring three others in a February 2 airstrike in Somalia. It is only the second time Africom has admitted to killing civilians in its Africa operations since it began reporting. The strike took place near Jilib, an area south of Somalias capital Mogadishu. The Feb. 2 killing had been highlighted in a report by Amnesty International in March, and at the time U.S. officials maintained that only terrorists had been killed in the operation. Africoms commander, Gen. Stephen Townsend said the military did not intend to target civilians in their operations against al-Shabab. We work hard to prevent civilians from getting hurt or killed during these operations designed to bring increased security and stability to Somalia, Townsend said.

Powells view on economy. The monthly meeting of the U.S. Federal Reserves Federal Open Market Committee, which sets U.S. interest rates, takes place today in Washington. Although rates are expected to remain unchanged, Fed chief Jerome Powells subsequent press conference should give an insight into the direction central bankers see the U.S. economy going in the coming months and whether more intervention is needed.

Australia to increase cooperation with U.S. Australia has agreed to increased and regularized maritime cooperation with the United States in the South China Sea and the Indian Ocean following a meeting between the countries top defense and foreign-policy officials. The declaration does not mean Australia will join U.S. freedom of navigation operations in the disputed sea, a practice that Beijing deems provocative. Australian Foreign Affairs Minister Marise Payne told reporters that Australia has no intention of injuringits relationship with China, its number one trade partner. A joint statement also announced the formation of a U.S.-Australian working group to respond to disinformation efforts in the region.

Biden to announce running mate. Former Vice President Joe Biden, the Democratic party nominee for president told reporters on Tuesday that he will announce his choice of running mate by next week. Biden has promised to choose a woman for the role, although there is not yet a clear frontrunner. On Tuesday, Biden was photographed with handwritten notes with a list of positive talking points about California Senator Kamala Harris. Politico also accidentally published a page on its website which named Harris as Bidens running mate, before it was swiftly updated and the claim was removed.

In a development that may have been more welcome in the earliest stage of lockdown, when bread-baking and gardening were in vogue, residents in more than a dozen U.S. states have reported receiving suspicious packages of seeds, apparently from China. The U.S. Department of Agriculture is investigating the mystery, and has advised anyone who has received the seeds to refrain from planting them. It is speculated that the seeds may have been part of a brushing scam, whereby products are shipped to unwitting addressees in order to create a fraudulent (but authentic-looking) review online in order to drive sales. At this point in time, we dont have enough information to know if this is a hoax, a prank, an internet scam or an act of agricultural bio-terrorism, Ryan Quarles, the Kentucky agriculture commissioner, said.

Thats it for today.

For more from FP, visit foreignpolicy.com, subscribe here, or sign up for our other newsletters. Send your tips, comments, questions, or corrections to morningbrief@foreignpolicy.com.

Read more from the original source:

Why Big Tech Is Colliding With Washington - Foreign Policy

Republicans Are Mad At Big Tech For All The Wrong Reasons – Vanity Fair

Wednesdays House Judiciary Committee hearing represents a rare opportunity for Congress: to hold the leaders of the biggest technology companies feet to the fire, with an eye toward reining in their expansive and largely unchecked power. But a memo obtained by Politico Tuesday on the eve of the hearing suggests Republicans plan to squander that chance, with GOP members of the panel preparing to set aside the very real antitrust issues raised by Facebook, Google, Apple, and Amazonand, instead, to use their time to probe the Big Four on the very not real issue of anti-conservative bias at the companies.

Political bias in big tech should be decried, the memo reads, but antitrust wont solve it.

Amazons Jeff Bezos, Apples Tim Cook, Google-parent Alphabets Sundar Pichai, and Facebooks Mark Zuckerberg are all due on Capitol Hill Wednesday for a highly-anticipated clash between the countrys most powerful tech leaders and the Congressional committee aiming to curb them. But while distrust of the Big Four is bipartisan, Republicans are attacking the companies for all the wrong reasons. Democrats are concerned about what seems to be monopolistic behavior, as well as the role of Facebook and other social media platforms in the spread of false and misleading information and in foreign election interference. These platforms have been allowed to run wild and free from really any constraints, David Cicilline, chair of the House Antitrust Subcommittee, told the Wall Street Journal. The responsibility we have is to make clear what the impacts are of the lack of competition in the digital marketplace.

But Republicans seem less concerned with the potential antitrust abuses that have led to calls from Elizabeth Warren and others on the left to break up big tech. Conservatives, instead, have based their Silicon Valley attacks on the notion that these firms and their leaders have it in for theman idea that simply isnt rooted in reality. Donald Trump and his allies have long belly-ached that social media companies are working to undermine him; just this week, he whined, ludicrously, that Twitters trending topics about him are ridiculous, illegal, and, of course, very unfair! So disgusting to watch Twitters so-called Trending, where sooo many trends are about me, and never a good one, the president wrote, in the middle of a pandemic thats killed more than 150,000 Americans. They look for anything they can find, make it as bad as possible, and blow it up, trying to make it trend. Thats not quite how it works, of course, and while Twitter chief Jack Dorsey has shown some spine recently in labeling or removing Trumps tweets that are dangerous or false, the president remains the sites most prominent user, and he continues to reap massive benefit from the megaphone it has provided him.

Of course, Zuckerberg has resisted even the kind of careful measures Dorsey has implemented to police hate and misinformation on his platform. On the contrary, Zuckerberg has courted the president and other conservatives in recent months, and his company has become a home to the right, which has used the platform as a dumping ground for conservative views and conspiracy theoriesmuch to the chagrin of rank-and-file employees, who have been increasingly open about their frustrations with Zuck, Sheryl Sandberg, and other company leaders.

Republicans are likely to point to some high-profile episodes, like Donald Trump Jr. and other Republicans having their Twitter accounts suspended and videos removed from Facebook after recklessly posting disinformation about a disproven COVID-19 therapy promoted by the president, as evidence they are being censored. Big Tech is intent on killing free expression online, Trump Jr. spokesman Andy Surabian told the Washington Post after the presidents son had his Twitter account suspended. But the president's son didnt have his account temporarily restricted over partisan speech; he got a time-out for blasting false and irresponsible claims about a public health crisis.

That these platforms, with broad and mostly unbridled power, have the potential to disseminate such dangerous lies and conspiracy theories is a far more pressing issue. Lawmakers on Wednesday have a real opportunity to challenge Americas most prominent tech leaders on their anti-competitive behavior and its impact on both democracy and everyday Americans but itll be wasted if Republicans spend their time stunting about nonexistent anti-conservative censorship and prosecuting Trumps petty crusade against Bezos.

More Great Stories From Vanity Fair

As Chaos Engulfs Trump Campaign, Loyalists Look For the Next Thing In Mary Trumps New Book, a Conclusive Diagnosis of Donald Trumps Psychopathology For Some on Wall Street Beating Trump Is More Important Than Money Bill Barr Is Running an October-Surprise Factory at Justice Bari Weiss Makes Her Bid for Woke-Wars Martyrdom Inside the Cult of Trump, His Rallies Are Church and He Is the Gospel From the Archive: Untangling the Symbiosis of Donald Trump and Roy Cohn

Looking for more? Sign up for our daily Hive newsletter and never miss a story.

See the rest here:

Republicans Are Mad At Big Tech For All The Wrong Reasons - Vanity Fair

Are the Big Tech companies breaking antitrust rules? Their CEOs testify before Congress. – Marketplace

Amazons Jeff Bezos, Apples Tim Cook, Googles Sundar Pichai and Facebooks Mark Zuckerberg, CEOs of four of the worlds most powerful companies, are testifying before Congress Wednesday.

Specifically, they are going before the Houses Subcommittee on Antitrust, Commercial, and Administrative Law, and the issue here boils down to power. How did these companies get it? Did they do so legally, or did they break rules? Finally, do they have too much power?

Erik Gordon, professor at the University of Michigans Ross School of Business, spoke with host Sabri Ben-Achour. The following is an edited transcript of their conversation.

Sabri Ben-Achour: So can you explain why this hearing is happening? And, specifically, why this question of how these companies became so powerful and whether they did so legally is an issue right now?

Erik Gordon: The hearing is happening because members of Congress think that these companies are really powerful, and that theyre abusing their power, and that Congress should look into it and maybe pass some new laws. The question you brought up is the key question. Under current antitrust law, its perfectly OK to be big and to be powerful, and, in fact, to be a monopoly, as long as you got big and powerful by lawful means, as long as you didnt do anything illegal. The government cant break you up, under current law, just for being big.

Ben-Achour: So whats an example of how, say, Google or Facebook or whichever might have accumulated power illegally?

Gordon: Suppose you have a dominant online search engine, and you use that search engine dominance to make you even more powerful in an other area. So, for example, suppose you say, You can only use my search engine, if you use my browser. Now you get big and powerful in the browser business, because you already had power in the search engine business. That would be an example of getting bigger and more powerful illegally.

Ben-Achour: Do you think anything significant will come out of these hearings? Or are they sort of theatrical?

Gordon: I have a sense that in an election year, were going to see some theater. Its an opportunity for politicians to control the questions. They get to put together some nice sound bites for their campaign. This isnt the first round of hearings we had, and in the other hearings, where there were some beat-ups of Zuckerberg and other tech people, oh, a few bills were introduced in Congress. They didnt go anywhere. Nothing much happened.

As a nonprofit news organization, our future depends on listeners like you who believe in the power of public service journalism.

Your investment in Marketplace helps us remain paywall-free and ensures everyone has access to trustworthy, unbiased news and information, regardless of their ability to pay.

Donate today in any amount to become a Marketplace Investor. Now more than ever, your commitment makes a difference.

Read more:

Are the Big Tech companies breaking antitrust rules? Their CEOs testify before Congress. - Marketplace

Congress is going to ask Big Techs leaders all the wrong questions. Here are the right ones – San Francisco Chronicle

Welcome back to Tech Chronicle. If you want something thats not afraid to compete for your attention, try this fine newsletter.

The House Subcommittee on Antitrust, Commercial and Administrative Law, after a brief delay, is summoning Big Tech to explain itself Wednesday. Called to testify are the CEOs of Alphabet, Amazon, Apple and Facebook.

Together, Sundar Pichai, Jeff Bezos, Tim Cook and Mark Zuckerberg oversee companies worth about $6.3 trillion. They didnt get that way by being shy about crushing the competition. Remember Cuil? Quidsi? Palm? Path? Exactly.

If youre the drinking type, pour a shot every time you hear a CEO talk about obsessing about customers, not competitors; worrying about Chinese competitors waiting in the wings; making a positive difference in society; and having pathetically small market share, really, if you just count it correctly.

Expect a lot of naive, time-wasting questions from our elected representatives. If you remember Zuckerbergs four-hour House hearing in 2018, it wasnt exactly a shining moment for Congress. (You love America, we know that was one memorable quote.)

If subcommittee members were serious, heres what theyd ask:

Where do you get the data that informs your decisions to buy smaller tech companies? Amazon, Apple, Facebook and Alphabets Google all have unique lenses into online activity, and the cloud infrastructure they are building just adds to their ability to surveil smaller rivals before they become real challengers. One clue Zuckerberg had about Instagrams early hypergrowth was the number of photos users were posting from the startups mobile app to Facebooks social network.

What tools do you have to retaliate against startups that refuse to sell to you? Amazon threatened a price war against Quidsi before buying it. After Twitter turned down a Facebook buyout offer, Facebook turned off access to its friends lists.

Do users have a reasonable way to extract their personal data and share it with competitors? Most big tech companies offer some kind of way to export user data. That doesnt mean its useful.

How do you restrain entrepreneurs who sell their startups to you from starting new competitive ventures? The best way Silicon Valley has of self-regulating against would-be monopolists is its ability to churn out new startups. Noncompete agreements prevent that from happening.

I dont expect any of these topics to come up at the Wednesday hearing, because posturing and lecturing is a lot easier. But in between shots, there might be room for hope.

Owen Thomas, othomas@sfchronicle.com

Related Stories

Hopefully theyll look to the facts, understand the values of the people that theyre thinking about and understand that were in this together. Microsoft co-founder Bill Gates, speaking to CNBC on the prospects for public acceptance of a coronavirus vaccine

From Capitol Hill to Wall Street: Apple, Facebook and Alphabet report earnings Thursday, the day after their CEOs wrap up their congressional testimony.

Dana Mattoli and Cara Lombardo on Amazons habit of competing with startups it invests in. (Wall Street Journal)

Roland Li on Googles long-term work-from-home plans. (San Francisco Chronicle)

Teddy Schleifer on Peter Thiels latest political backing of restrictions on immigration. (Recode)

Tech Chronicle is a weekly newsletter from Owen Thomas, The Chronicles business editor, and the rest of the tech team. Follow along on Twitter: @techchronicle and Instagram: @techchronicle

View original post here:

Congress is going to ask Big Techs leaders all the wrong questions. Here are the right ones - San Francisco Chronicle

What to watch today: Dow to open higher ahead of Big Tech hearing and Fed policy decision – CNBC

BY THE NUMBERS

Dow futures indicated a roughly 70-point gain at the opening bell, ahead of a blockbuster Big Tech congressional hearing, a Fed policy statement and another batch of corporate earnings reports. S&P 500 and Nasdaq futures also were mildly higher. The Dow on Tuesday fell about 205 points, or .77%. The S&P 500 gave up .65% while the tech-heavy Nasdaq Composite sank 1.27%.

The Dow, S&P 500 and Nasdaq have fallen in three of the past four trading days, although all remain on course for solid July gains. The Dow begins the new day at a more than two-week low, coming off its lowest close since July 13.

*Treasury yields edge higher ahead of Fed interest rate decision (CNBC)

The Federal Reserve's Open Market Committee will issue its latest policy statement at 2:00 p.m. ET, followed by Fed Chairman Jerome Powell's virtual news conference 30 minutes later.

General Electric (GE), Boeing (BA), and General Motors (GM) lead a long list of morning earnings reports; streaming service Spotify (SPOT) also reports. After the bell, PayPal (PYPL), Qualcomm (QCOM) and Yum China (YUMC) are scheduled to post quarterly earnings.

*GM swings to a loss as coronavirus shuttered factories and devastated sales (CNBC)*GE reports quarterly loss as coronavirus pandemic hits hard (Reuters)*Boeing posts net loss of $2.4 billion and slows aircraft production amid coronavirus-weakened demand (CNBC)

Total mortgage application volume fell 0.8% last week from the previous week, according to theMortgage Bankers Association's latest report.Mortgage applications to buy a home were down 2% last week compared to the prior week but 21% higher annually. (CNBC)

The CEOs of Amazon, Apple, Google-parent Alphabet and Facebookare set to testify in front the House Antitrust Subcommittee later today. The blockbuster virtual hearing will be Amazon chief executive Jeff Bezos' first congressional testimony. It comes as part of the House Judiciary Committee's investigation into Big Tech and potential anti-competitive practices. Mark Zuckerberg is expected to defend Facebook's acquisitions of Instagram and WhatsApp, portraying them as key to creating better services for both users and advertisers. (CNBC)

*Jeff Bezos will testify about how Amazon is the quintessential American company (CNBC)*Google CEO Sundar Pichai plans to tell Congress the company faces plenty of competition (CNBC)*Tim Cook will testify that Apple is in fierce competition with Google and Huawei (CNBC)

Biotech firm Moderna (MRNA) is planning to price its potential coronavirus vaccine at $50 to $60 per course for high-income countries, according to a Financial Times report. The price for the two-dose vaccine comes in higher than the proposed price from Pfizer(PFE) and German-based BioNTech, according to Reuters, based on the companies' $1.95 billion deal with the U.S. government to produce and deliver 100 million doses. The price for Moderna's vaccine, which entered late-stage human trials earlier this week, is not finalized, Reuters reported. (FT)

Hong Kong is increasing its restrictions to curb the spread of Covid-19 as local officials warn the city is at risk of a large-scale virus outbreak. There's been an "upsurge" in local infections, said Chief ExecutiveCarrie Lam, who warned of overrunning the health-care system. The government is banning gatherings of more than two people, suspending indoor dining at restaurants and requiring face masks in public. (Reuters)

*Europe scrambles to avoid a second coronavirus wave, as infections rise (Washington Post)

The U.S. Senate will not pass a coronavirus relief bill that does not have liability shields for businesses and universities, Majority LeaderMitch McConnelltold CNBC. The Kentucky Republican said Tuesday on "Closing Bell" that the GOP was "not negotiating over liability protection," but he added the party was open to compromise with Democrats on other issues. Senate Republicans released their roughly $1 trillion legislative proposal on Monday. (CNBC)

*Most swing state voters support extending $600 weekly unemployment benefit, CNBC/Change Research poll finds(CNBC)

The Trump administration has started negotiations with the office of Oregon's governor over the presence of federal agents in Portland, according to the Associated Press, expressing a willingness to scale back if the state increases its own enforcement in the city, which has seen nearly two months of nightly protests in the wake of George Floyd's death. The talks are still in the early stages and no agreement is in place, the wire service reported. (AP)

*Portland protests bring early-morning clash with feds after more than 1,000 turn out Tuesday (The Oregonian)* Attorney General Barr, grilled by House Democrats, defends aggressive federal response in Portland (LA Times)

In a historic move,AMC Theaters(AMC) and Comcast-ownedUniversal Picturesinked an agreement to shorten the theatrical release window for Universal's movies, allowing them to head to digital streaming just 17 days after their debut on the big screen. Theaters previously would have the exclusive rights to films for about 90 days. AMC will share in some of the new revenue from the digital on-demand rentals. Comcast is parent company of CNBC and NBCUniversal. (CNBC)

Starbucks (SBUX) exceeded Wall Street expectations in its earnings report and raised its adjusted earnings outlook for the fiscal fourth quarter, sending its stock up more than 5% in premarket trading. The coffee chain expressed optimism about its recovery from the coronavirus in the U.S. and China, although it saw global same-store sales plunge 40% in the quarter. (CNBC)

*Restaurant transactions plateau as coronavirus cases surge (CNBC)

The American Federation of Teachers, one of the largest teachers' unions in the U.S., will support any of its local chapters that decide to strike if they feel school reopening plans are not safe enough. The federation, which represents 1.7 million school employees, said in its Tuesday resolution that striking should be the last option, but it called for reopening plans to include social distancing measures and mask requirements. It also said buildings should only reopen in places where coronavirus transmission rates are low. (USA Today)

Visa (V) came in 4 cents above estimates with quarterly earnings of $1.07 per share, with revenue above estimates as well. The payments processor did say that payment volume was down 10% during the quarter with profit dropping 23%, as consumer spending was hit by rising unemployment.

Mondelez (MDLZ) reported adjusted quarterly profit of 63 cents per share, 7 cents above estimates, with the snack maker's revenue slightly above Wall Street forecasts. Strong demand for its snacks in North America helped offset other declines, and Mondelez also announced an 11% dividend increase.

FireEye (FEYE) surprised analysts who had expected a loss by reporting an adjusted profit of 9 cents per share with revenue above estimates as well. The cybersecurity company benefited from the shift to cloud-based work amid the pandemic.

Avis Budget (CAR) reported a quarterly loss of $5.60 per share, slightly smaller than the loss of $5.68 that analysts were expecting. The car rental's revenue beat estimates, with a recovering used car market and increased leisure rentals helping results.

L Brands (LB) is cutting 15% of its corporate staff, amounting to 850 jobs. The parent of Victoria's Secret and Bath & Body Works also projected a smaller than expected current quarter sales decline.

Spirit Airlines (SAVE) will tell its unions to be prepared for possible October furloughs of 20 to 30% of workers, according to a memo sent to employees and first reported by Reuters.

Advanced Micro Devices (AMD) beat estimates by 2 cents with adjusted quarterly profit of 18 cents per share, with the chip maker's revenue above estimates as well. AMD also raised its full-year forecast, as the surge in the number of employees working from home raises demands for its chips.

EBay (EBAY) reported adjusted quarterly earnings of $1.08 per share, 2 cents above estimates, with the e-commerce company's revenue also beating forecasts. It also raised its full-year outlook, amid more online shopping by people staying indoors during the coronavirus pandemic.

Amgen (AMGN) earned an adjusted $4.25 per share for its latest quarter, compared to a $3.82 consensus estimate, with revenue above forecasts as well. The biotech company was helped by stronger sales of its newer drugs.

Budweiser has unveiled its newest beer with a twist. It has no alcohol. The 50-calorie Bud Zero is now going out nationwide and was created with the help of former NBA star Dwyane Wade. The new drink gives Anheuser Busch Inbev (BUD) further exposure to the non-alcoholic beer category, which has been growing fast this year. (USA Today)

Read more:

What to watch today: Dow to open higher ahead of Big Tech hearing and Fed policy decision - CNBC

Ahead of Big Tech Hearing, Less Than Half of the Public Trusts Congress to Best Regulate the Industry – Morning Consult

July 29, 2020 at 12:01 am ET

55% of adults, including 64% of Democrats and 56% of Republicans, said they believe Congress has a lot or some understanding of how to regulate the tech industry.

Republicans were most likely to trust the president (70%) with regulating the industry in the best way.

With the House antitrust subcommittee ready to pull out all the stops ahead of todays hearing with the chief executives of Amazon.com Inc., Apple Inc., Alphabet Inc. and Facebook Inc., a new survey suggests that most of the public has little or no faith in Congress ability to regulate the tech industry.

More than half (55 percent) of the 2,200 adults surveyed in a Morning Consult poll conducted July 23-26 said they believe Congress had a lot or some understanding of how to regulate the technology industry, but they were 9 percentage points less likely, at 46 percent, to trust the lawmakers best to do so. Adults, regardless of party affiliation, were more likely to trust other government institutions, such as the court system (57 percent) and federal agencies (53 percent), to best regulate the sector.

The survey has a margin of error of 2 points.

Both Democrats and Republicans saw a nearly 10-point discrepancy between whether they believed Congress had at least some understanding of how to regulate tech companies and whether they trusted federal lawmakers to best approach such regulation. Among Democrats, 64 percent said they believed Congress understood the issue, while 56 percent said they had trust in the legislative branch an 8-point gap. Democrats were far more likely to trust members of their party (74 percent) and the courts (64 percent) with tech regulation than Capitol Hill.

And among Republicans, 56 percent said they believed Congress understood either a lot or some of the issues, but only 47 percent trusted them at least somewhat with doing so in the best way a 9-point dip. They were more inclined to say they trusted the president (70 percent) and fellow Republicans (67 percent).

Key members of the House Judiciary Committee will spend hours this afternoon seeking answers from the four tech executives Jeff Bezos, Tim Cook, Sundar Pichai and Mark Zuckerberg in response to a slew of allegations that their companies abuse their market power by making it harder for competitors to succeed in their respective industries. The hearing is expected to be the culmination of a nearly 14-month congressional investigation into the four tech giants, led by Rep. David Cicilline (D-R.I.), the antitrust subcommittees chairman. So far, the inquiry has yielded 1.3 million documents of evidence some of which could be unveiled during the hearing, senior congressional aides told reporters last week.

However, Congress has a history of failing to understand certain tech issues: When Googles Pichai last appeared before a congressional panel in December 2018, Rep. Steve King (R-Iowa) complained about a notification that appeared on his granddaughters iPhone, a product made by Apple Inc.

Underscoring the panels investigation, however, is an American public with mixed views on tech regulation. A plurality of adults (35 percent) said they didnt know or had no opinion on whether the federal government needs to regulate the tech industry more, less or exactly the same as it is doing currently. Thirty percent said the industry needs more regulation, while 24 percent said it was being regulated the right amount and 11 percent said the federal government should regulate it less.

And that sense of uncertainty goes hand-in-hand with how U.S. adults view the amount of power the tech industry has. When asked to choose which industry holds the most power and influence in America, technology in Silicon Valley ranked last: 6 percent picked tech, compared to 42 percent who chose politics in Washington. The share who picked the tech industry is statistically unchanged since the first time the question was asked in a February 2018 survey.

Get the latest global tech news and analysis delivered to your inbox every morning.

View post:

Ahead of Big Tech Hearing, Less Than Half of the Public Trusts Congress to Best Regulate the Industry - Morning Consult